Mangiferin, a polyphenol derived from Mangifera indica, exhibits a wide range of pharmacological activities, positioning it as a promising candidate for applications in medicine. Its potential as an alternative to antibiotics is especially significant in agriculture and medicine, addressing the global demand for non-traditional antibacterial agents. However, its poor water solubility and low bioavailability limit its therapeutic use. Polymeric matrices could be one of the potential approaches to solve these problems, enhancing mangiferin’s bioavailability. Each delivery system exhibits unique properties such as controlled release, prolonged action and organ-specific targeting, in an ideal case each directed to specific diseases and administration routes. While promising in vitro and in vivo results highlight their therapeutic potential, challenges remain in the optimization of the matrix formulations for precise applications. Further research is needed to develop these systems and confirm their efficacy in clinical practice.
The rise in antibiotic-resistant bacterial infections is a major global health concern. The search for natural compounds that inhibit the growth of pathogens is becoming urgent. One such compound is mangiferin, a non-toxic polyphenolic compound derived mainly from Mangifera indica. In addition to antibacterial properties, it exhibits anticancer, antioxidant, immunomodulatory, analgesic and other activities. However, the clinical application of mangiferin is limited by poor solubility and bioavailability. This study describes mangiferin-loaded electrospun nanofibers based on high-molecular-weight hyaluronic acid. The nanofibers improve mangiferin delivery and possess favorable morphological characteristics and drug release kinetics, making them promising candidates for effective antibacterial dressings. This study found that an increase in the mangiferin content of the fibers led to an increase in the average diameter of the fibers. It was also found that nanofibers with different mangiferin content have similar release kinetics with an anomalous non-Fickian transport pattern: most of the mangiferin is released within 10–15 min.
1 June 2023 in Bulletin of the Russian Academy of Sciences: Physics
A study is performed of the physical properties of aqueous organic spinning solutions based on hyaluronic acid with added mangiferin. Electrospinning is us
Currently, multidrug-resistant (MDR) bacteria are a global problem, which requires modern approaches and effective pharmaceutical agents. Substances isolated from nature sources have a strong potential in combating highly virulent and antibiotic-resistant microorganisms, including within the ESKAPE group (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp.). One of these substances is mangiferin, the bioactive compound obtained from parts of Mangiferin indica L. Mangiferin has a low aqueous solubility, which causes low activity and requires additional modification or delivery system to increase its concentration in the cell. Many studies show that it has multiple biological effects and can be used as an antioxidant or an anticancer agent, and it can exhibit antibacterial properties. Extracts obtained from plant parts show high efficacy in low doses against the ESKAPE group and other strains. This makes mangiferin a possible candidate as a strong agent against bacterial infections. The mechanisms underlying the action of mangiferin on bacterial cells are poorly understood. This review summarizes studies confirming the antibacterial properties of mangiferin both in its native form and using delivery systems.
30 December 2024 in Nanosystems: Physics, Chemistry, Mathematics
Introduction. Currently, the use of natural biologically active agents (BAA) as effective antibacterial drugs for both external and internal use is becoming widespread. Polyphenol mangiferin, extracted from the leaves of the Mangifera indica plant, is the most attractive BAA. Despite high antimicrobial activity against gram-positive and gram-negative strains of bacteria, the use of mangiferin is limited by its low aqueous solubility. To increase solubility and, accordingly, bioavailability, various approaches are used, in particular, encapsulation in polymer and biopolymer matrices. One of the promising biopolymers for the encapsulation of biologically active substances is hyaluronic acid, which is completely biocompatible with the tissues of a living organism and is capable of complete biodegradation under the influence of enzymes (hyaluronidases).Aim. Study of the release kinetics of the biologically active agent (mangiferin) from a polymer matrix based on hyaluronic acid with different molecular weights.Materials and methods. Polymer films obtained by casting method from 1.5 wt.% forming solutions of hyaluronic acid with a molecular weight of 1.30 and 2.48 MDa with different contents of mangiferin were used as the objects of the study. The weight ratio of hyaluronic acid to mangiferin varied from 5 to 25. Released mangiferin was measured by UV/Vis spectrophotometry at a wavelength of 237 nm. A phosphate buffered saline with pH 7.4 was used as a model medium. The mangiferin release kinetic was assessed using various mathematical models.Results and discussion. Mangiferin release kinetic from a polymer matrix based on hyaluronic acid has a release sigmoidal pattern. The release mechanism has a complex nature of the Super Case II transport type, with the exception of a sample with a low content of mangiferin and hyaluronic acid with molecular weight equal to 1.3 MDa, for which an abnormal release pattern is detected (non-Fickian diffusion), due to the hydrophilic nature of hyaluronic acid, the rapid swelling of the polymer matrix, as well as a significant leading in the diffusion of mangiferin compared to the relaxation rate of the polymer. The most suitable model is the Weibull model, which describes the mangiferin release kinetics with greater accuracy compared to other mathematical models.Conclusion. The results obtained indicate the potential possibility of using the developed polymer films as biomedical materials for external use, which provide transdermal delivery of pharmaceutical agents. The authors of the study are planning to develop a methodology for prolonged and controlled release of a loaded biologically active agent, including by various cross-linking agents.